Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

BackgroundRegulatory bodies have recently approved chimeric antigen receptor (CAR)-T cell therapies for patients with multiple myeloma (MM), but the treatment process involves complex decision making. To support the introduction of these therapies, we aimed to establish consensus expert opinion on b...

Full description

Bibliographic Details
Main Authors: P. Joy Ho, Hang Quach, M. Hasib Sidiqi, Cindy H. Lee, Jason Butler, Andrew Spencer, Kenneth Micklethwaite, Jingya Li, Elissa Cusson, Robert Bagnall, Simon J. Harrison
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
chimeric antigen receptor immunotherapy
CAR-T cell therapy
systematic review
Delphi study
multiple myeloma
consensus development
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1535869/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1535869/full

Similar Items